Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/27/12 → 1/27/18 |
Funding
- PPD Development (7389-G000-309 // 7389-G000-309)
- Eisai, Inc. (7389-G000-309 // 7389-G000-309)
Prot#7389-G000-309: A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin with Dacarbazine in Subjects with Soft Tissue Sarcoma.
- Agulnik, Mark (PD/PI)
Project: Research project